Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - Deferred ChargesAmortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cellebrite DI (CLBT) Other Operating Expenses: 2020-2025

Historic Other Operating Expenses for Cellebrite DI (CLBT) over the last 5 years, with Sep 2025 value amounting to -$47.8 million.

  • Cellebrite DI's Other Operating Expenses fell 247.26% to -$47.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$169.3 million, marking a year-over-year decrease of 233.88%. This contributed to the annual value of -$199.9 million for FY2024, which is 396.77% down from last year.
  • Per Cellebrite DI's latest filing, its Other Operating Expenses stood at -$47.8 million for Q3 2025, which was down 12.78% from -$42.4 million recorded in Q2 2025.
  • Cellebrite DI's 5-year Other Operating Expenses high stood at $32.5 million for Q3 2024, and its period low was -$47.8 million during Q3 2025.
  • Moreover, its 3-year median value for Other Operating Expenses was $26.9 million (2023), whereas its average is $3.5 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first spiked by 40.81% in 2022, then tumbled by 247.26% in 2025.
  • Quarterly analysis of 5 years shows Cellebrite DI's Other Operating Expenses stood at $21.2 million in 2021, then increased by 11.44% to $23.7 million in 2022, then increased by 25.03% to $29.6 million in 2023, then slumped by 235.49% to -$40.1 million in 2024, then crashed by 247.26% to -$47.8 million in 2025.
  • Its last three reported values are -$47.8 million in Q3 2025, -$42.4 million for Q2 2025, and -$38.9 million during Q1 2025.